<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2631-2581</journal-id>
<journal-title><![CDATA[Revista Ecuatoriana de Neurología]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Ecuat Neurol]]></abbrev-journal-title>
<issn>2631-2581</issn>
<publisher>
<publisher-name><![CDATA[Sociedad Médica Ecuatoriana de Neurología]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2631-25812019000100021</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Adherencia Al Tratamiento Antiepiléptico En Pacientes Pediátricos Del Hospital Roberto Gilbert Elizalde En El Año 2014]]></article-title>
<article-title xml:lang="en"><![CDATA[Adherence To Antiepileptic Treatment In Pediatric Patients At Hospital Roberto Gilbert Elizalde During 2014]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Meza-Venegas]]></surname>
<given-names><![CDATA[Joyce]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Valverde-Regalado]]></surname>
<given-names><![CDATA[Cristian]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Vélez-Galárraga]]></surname>
<given-names><![CDATA[María del Rosario]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Jarri&#769;n-Sa&#769;nchez]]></surname>
<given-names><![CDATA[Sandra]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Católica de Santiago de Guayaquil Carrera de Medicina ]]></institution>
<addr-line><![CDATA[Guayaquil ]]></addr-line>
<country>Ecuador</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Roberto Gilbert Elizalde Servicio de Neurología ]]></institution>
<addr-line><![CDATA[Guayaquil ]]></addr-line>
<country>Ecuador</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2019</year>
</pub-date>
<volume>28</volume>
<numero>1</numero>
<fpage>21</fpage>
<lpage>25</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.senescyt.gob.ec/scielo.php?script=sci_arttext&amp;pid=S2631-25812019000100021&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.senescyt.gob.ec/scielo.php?script=sci_abstract&amp;pid=S2631-25812019000100021&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.senescyt.gob.ec/scielo.php?script=sci_pdf&amp;pid=S2631-25812019000100021&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen  Introducción:  La epilepsia en población pediátrica es una entidad que afecta más a países subdesarrollados. En Ecuador, los ingresos hospitalarios por el mal control de la misma van en aumento habiéndose constatado que la principal causa es una deficiente adherencia al tratamiento antiepiléptico.  Objetivo: Demostrar la incidencia de la no adherencia al esquema antiepiléptico y determinar los factores que contribuyen a la misma.  Materiales y métodos:  Se realizó un estudio transversal en el cual se incluyeron 119 pacientes entre 6 meses y 17 años. Los padres o tutores legales fueron interrogados respecto al grado de adherencia al tratamiento antiepiléptico utilizando el cuestionario de Morisky. Se usó un modelo de regresión logística para medir la fuerza de asociación entre variables.  Resultados:  Se encontró una incidencia de no adherencia al tratamiento antiepiléptico de 36,97%. Las variables significativamente asociadas fueron la escolaridad de la madre (p=0.018), la información médica previa (p=0.02) y el dejar de darle medicación por falta de dinero (p=0.01).  Conclusión: La incidencia de la no adherencia en este estudio fue alta; controlar factores sociodemográficos y relacionados al tratamiento pueden tener un gran impacto en estos pacientes.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract  Introduction:  Epilepsy in the pediatric population is an entity that mostly affects underdeveloped countries. In Ecuador, hospital admissions due to poor control are increasing and the main cause is poor adherence to antiepileptic treatment.  Objective:  To demonstrate the incidence of nonadherence to the antiepileptic regimen and determine the factors that contributes to it.  Materials and methods:  A cross-sectional study was conducted in which 119 patients were included with ages between 6 months and 17 years. The parents or legal guardians were questioned regarding the degree of adherence to antiepileptic treatment using the Morisky questionnaire. A logistic regression model was used to measure the strength of association between variables.  Results:  An incidence of non-adherence to antiepileptic treatment of 36.97% was found. The significantly associated variables were the mother's schooling (x2=11.83, IC= 10.13 - 13.53, p=0.018), previous medical information (x2=9.35, IC= 7.95 - 10.75, p=0.02) and the failure to obtain medication due to lack of money (x2=5.98, IC= 5.29 - 6.67, p=0.01).  Conclusion:  The incidence of nonadherence in this study was high; control over sociodemographic factors and related to treatment can have a great impact on these patients.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[epilepsia]]></kwd>
<kwd lng="es"><![CDATA[pediatría]]></kwd>
<kwd lng="es"><![CDATA[adherencia]]></kwd>
<kwd lng="es"><![CDATA[tratamiento.]]></kwd>
<kwd lng="en"><![CDATA[epilepsy]]></kwd>
<kwd lng="en"><![CDATA[pediatrics]]></kwd>
<kwd lng="en"><![CDATA[adherence]]></kwd>
<kwd lng="en"><![CDATA[treatment.]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Health and economic benefits of public financing of epilepsy treatment in India: An agent-based simulation model]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Megiddo]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Colson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Chisholm]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Dua]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Nandi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Laxminarayan]]></surname>
<given-names><![CDATA[R.]]></given-names>
</name>
</person-group>
<source><![CDATA[Official Journal of the International League Against Epilepsy]]></source>
<year>2016</year>
</nlm-citation>
</ref>
<ref id="B2">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Camas y Egresos Hospitalarios]]></article-title>
<collab>Censos I</collab>
<source><![CDATA[Instituto Nacional de Estadística y Censos]]></source>
<year>2018</year>
</nlm-citation>
</ref>
<ref id="B3">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Patterns of Nonadherence to Antiepileptic Drug Therapy in Children With Newly Diagnosed Epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Modi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[JAMA]]></source>
<year>2011</year>
<volume>305</volume>
<numero>16</numero>
<issue>16</issue>
<page-range>1669</page-range></nlm-citation>
</ref>
<ref id="B4">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[ADHERENCIA AL TRATAMIENTO: CONCEPTO Y MEDICIÓN]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[López-Romero]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Romero-Guevara]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Parra]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Rojas-Sánchez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Hacia la promoción de la salud]]></source>
<year>2016</year>
<volume>0121-7577</volume>
<numero>2462-8425</numero>
<issue>2462-8425</issue>
<page-range>117-37</page-range></nlm-citation>
</ref>
<ref id="B5">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Definitions, variants, and causes of nonadherence with medication: a challenge for tailored interventions. Patient Preference and Adherence]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hugtenburg]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Vervloet]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[van-Dijk]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Timmers]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Doverpress]]></source>
<year>2013</year>
<page-range>675</page-range></nlm-citation>
</ref>
<ref id="B6">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adherence to treatment in patients with epilepsy: Associations with seizure control and illness beliefs]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Jones]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Butler]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Thomas]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Peveler]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Prevett]]></surname>
<given-names><![CDATA[M.]]></given-names>
</name>
</person-group>
<source><![CDATA[Seizure]]></source>
<year>2006</year>
<volume>15</volume>
<numero>7</numero>
<issue>7</issue>
<page-range>504-8</page-range></nlm-citation>
</ref>
<ref id="B7">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Factors associated with treatment non-adherence in patients with epilepsy in Brazil]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferrari]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[de-Sousa]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Seizure]]></source>
<year>2013</year>
<volume>22</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>384-9</page-range></nlm-citation>
</ref>
<ref id="B8">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Outcome of Newly Diagnosed Epilepsy in Children: &#8220;Drugs Don't Work in Patients Who Don't Always Take Them&#8221;.]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hesdorffer]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy Currents]]></source>
<year>2015</year>
<volume>15</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>70-1</page-range></nlm-citation>
</ref>
<ref id="B9">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[ILAE classification of epilepsy syndromes]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Engel]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy Research]]></source>
<year>2006</year>
<volume>70</volume>
<page-range>5-10</page-range></nlm-citation>
</ref>
<ref id="B10">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Prevalence and cost of nonadherence with antiepileptic drugs in an adult managed care population]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Davis]]></surname>
<given-names><![CDATA[KL]]></given-names>
</name>
<name>
<surname><![CDATA[Candrilli]]></surname>
<given-names><![CDATA[SD]]></given-names>
</name>
<name>
<surname><![CDATA[Edin]]></surname>
<given-names><![CDATA[HM]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsia]]></source>
<year>2008</year>
<volume>49</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>446-54</page-range></nlm-citation>
</ref>
<ref id="B11">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Patients&#8217; perspectives on antiepileptic medication: relationships between beliefs about medicines and adherence among patients with epilepsy in UK primary care]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Chapman]]></surname>
<given-names><![CDATA[SC]]></given-names>
</name>
<name>
<surname><![CDATA[Horne]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Chater]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Hukins]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Smithson]]></surname>
<given-names><![CDATA[WH]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy and Behavior]]></source>
<year>2014</year>
<volume>31</volume>
<page-range>312-20</page-range></nlm-citation>
</ref>
<ref id="B12">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Compliance with health regimens of adolescents with epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kyngas]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Seizure]]></source>
<year>2000</year>
<volume>9</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>598-604</page-range></nlm-citation>
</ref>
<ref id="B13">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Factors associated with treatment non-adherence in patients with epilepsy in Brazil]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ferrari]]></surname>
<given-names><![CDATA[CM]]></given-names>
</name>
<name>
<surname><![CDATA[De-Sousa]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
<name>
<surname><![CDATA[Castro]]></surname>
<given-names><![CDATA[LHM]]></given-names>
</name>
</person-group>
<source><![CDATA[Seizure]]></source>
<year>2013</year>
<volume>22</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>384-9</page-range></nlm-citation>
</ref>
<ref id="B14">
<nlm-citation citation-type="book">
<article-title xml:lang=""><![CDATA[Ethiopian Central Statistics Agency and ICF International, Ethiopia Demographic and Health Survey 2011]]></article-title>
<source><![CDATA[CSA]]></source>
<year>2012</year>
<publisher-loc><![CDATA[Ethiopia ]]></publisher-loc>
<publisher-name><![CDATA[Addis Ababa]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B15">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Adherence to antiepileptic drugs and beliefs about medication among predominantly ethnic minority patients with epilepsy]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nakhutina]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Gonzalez]]></surname>
<given-names><![CDATA[JS]]></given-names>
</name>
<name>
<surname><![CDATA[Margolis]]></surname>
<given-names><![CDATA[SA]]></given-names>
</name>
<name>
<surname><![CDATA[Spada]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Grant]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[Epilepsy &amp; Behavior]]></source>
<year>2011</year>
<volume>22</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>584-6</page-range></nlm-citation>
</ref>
<ref id="B16">
<nlm-citation citation-type="journal">
<article-title xml:lang=""><![CDATA[Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya]]></article-title>
<person-group person-group-type="author">
<name>
<surname><![CDATA[Feksi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Kaamugisha]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Sander]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Shorvon]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Gatiti]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[The Lancet]]></source>
<year>1991</year>
<volume>337</volume>
<numero>8738</numero>
<issue>8738</issue>
<page-range>406-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
